TytoCare’s FDA-cleared AI devices and $25M funding highlight how remote monitoring cuts hospital visits and improves outcomes for CHF and COPD patients. AI-driven remote monitoring is shifting c...
Adherence quietly decides type 2 diabetes outcomes, and it happens where most healthcare software isn’t — the between-visit gap. A structured self-management program on infrastructure the clin...